Medicure Inc. (CVE:MPH – Get Free Report)’s share price passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$1.04 and traded as low as C$1.01. Medicure shares last traded at C$1.01, with a volume of 3,000 shares changing hands.
Medicure Price Performance
The company has a quick ratio of 1.29, a current ratio of 1.87 and a debt-to-equity ratio of 2.06. The firm’s 50-day moving average is C$1.04 and its 200-day moving average is C$1.07. The company has a market cap of C$10.54 million, a PE ratio of -4.04 and a beta of 0.90.
Medicure (CVE:MPH – Get Free Report) last released its earnings results on Wednesday, August 14th. The company reported C($0.12) earnings per share for the quarter. Medicure had a negative return on equity of 12.90% and a negative net margin of 12.56%. The business had revenue of C$5.17 million during the quarter. On average, equities analysts anticipate that Medicure Inc. will post 0.0756677 EPS for the current year.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Articles
- Five stocks we like better than Medicure
- The 3 Best Blue-Chip Stocks to Buy Now
- The Average 401k Balance by Age Explained
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
